-
Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection FractionSD Solomon, the PARAGON-HF Investigators and Committees. JohnJV McMurray, -
H2FPEF Score for Predicting Future Heart Failure in Stable Outpatients With Cardiovascular Risk FactorsSatoru Suzuki , K Kaikita, E Yamamoto et al.
-
Impact of Myocardial Scar on Prognostic Implication of Secondary Mitral Regurgitation in Heart FailureB Tayal, D Debs, F Nabi et al.
-
Empagliflozin Increases Cardiac Energy Production in Diabetes - Novel Translational Insights Into the Heart Failure Benefits of SGLT2 InhibitorsS Verma, S Rawat, KL Ho et al.
-
Permanent pacemaker use among patients with heart failure and preserved ejection fraction: Findings from the Acute Decompensated Heart Failure National Registry (ADHERE) National RegistryKhazanie P, Hellkamp AS, Hernandez AF et al.
-
Modifiable lifestyle factors and heart failure: A Mendelian randomization studyS van Oort, JWJ Beulens, AJ van Ballegooijen et al.
-
Universal Definition and Classification of Heart Failure: A Report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart FailureB Bozkurt, AJS Coats, H Tsutsui et al.
-
The prevalence and importance of frailty in heart failure with reduced ejection fraction - an analysis of PARADIGM-HF and ATMOSPHEREDewan P, Jackson A, Jhund PS et al.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
